The three-dimensional solution structure and dynamic properties of the human FADD death domain.
暂无分享,去创建一个
A Sankar | H. Berglund | P. Driscoll | N. McDonald | D. Olerenshaw | A. Sankar | M. Federwisch | P C Driscoll | H Berglund | D Olerenshaw | M Federwisch | N Q McDonald | Paul C. Driscoll | Helena Berglund | Dionne Olerenshaw | Matthias Federwisch | Neil Q. McDonald
[1] R. Siegel,et al. Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal* , 1998, The Journal of Biological Chemistry.
[2] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[3] Y. Goltsev,et al. Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.
[4] Gregory L. Warren,et al. NMR structure calculation methods for large proteins Application of torsion angle dynamics and distance geometry/simulated annealing to the 269-residue protein serine protease PB92 , 1998 .
[5] G. Siegal,et al. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes. , 2000, Journal of molecular biology.
[6] Paul C. Driscoll,et al. Practical aspects of proton-carbon-carbon-proton three-dimensional correlation spectroscopy of 13C-labeled proteins , 1990 .
[7] A. Bax,et al. Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium. , 1997, Science.
[8] Axel T. Brunger,et al. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .
[9] M. Wittekind,et al. HNCACB, a High-Sensitivity 3D NMR Experiment to Correlate Amide-Proton and Nitrogen Resonances with the Alpha- and Beta-Carbon Resonances in Proteins , 1993 .
[10] L. Kay,et al. Gradient-Enhanced Triple-Resonance Three-Dimensional NMR Experiments with Improved Sensitivity , 1994 .
[11] E A Merritt,et al. Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.
[12] J. Camonis,et al. A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.
[13] Stephen W. Fesik,et al. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain , 1996, Nature.
[14] L. Kay. Pulsed-field gradient-enhanced three-dimensional NMR experiment for correlating 13C.alpha./.beta., 13C', and 1H.alpha. chemical shifts in uniformly carbon-13-labeled proteins dissolved in water , 1993 .
[15] L. Tartaglia,et al. A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.
[16] L. Kay,et al. Two-dimensional NMR experiments for correlating carbon-13.beta. and proton.delta./.epsilon. chemical shifts of aromatic residues in 13C-labeled proteins via scalar couplings , 1993 .
[17] Brent R. Stockwell,et al. An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.
[18] Richard R. Ernst,et al. Multiple quantum filters for elucidating NMR coupling networks , 1982 .
[19] N. Kabra,et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.
[20] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[21] Max F. Perutz,et al. Glutamine repeats and neurodegenerative diseases: molecular aspects. , 1999, Trends in biochemical sciences.
[22] A. Szabó,et al. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .
[23] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[24] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[25] A. Gronenborn,et al. Analysis of the backbone dynamics of interleukin-1.beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy , 1990 .
[26] Max F Perutz,et al. Glutamine repeats and neurodegenerative diseases , 1999, Brain Research Bulletin.
[27] D. Donner,et al. Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. , 1994, Journal of Biological Chemistry.
[28] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[29] P. J. Kraulis,et al. ANSIG: A program for the assignment of protein 1H 2D NMR spectra by interactive computer graphics , 1989, Journal of Magnetic Resonance (1969).
[30] W. Chazin,et al. High resolution solution structure of apo calcyclin and structural variations in the S100 family of calcium-binding proteins , 1999, Journal of biomolecular NMR.
[31] M. Peter,et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Kay,et al. Simultaneous Acquisition of 15N- and 13C-Edited NOE Spectra of Proteins Dissolved in H2O , 1994 .
[33] A M Gronenborn,et al. Determination of three-dimensional structures of proteins and nucleic acids in solution by nuclear magnetic resonance spectroscopy. , 1989, Critical reviews in biochemistry and molecular biology.
[34] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[35] G. Marius Clore,et al. Applications of three- and four-dimensional heteronuclear NMR spectroscopy to protein structure determination , 1991 .
[36] A. Bax,et al. Resolution enhancement and spectral editing of uniformly 13C-enriched proteins by homonuclear broadband 13C decoupling , 1992 .
[37] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[38] L. Kay,et al. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. , 1989, Biochemistry.
[39] A M Gronenborn,et al. New methods of structure refinement for macromolecular structure determination by NMR. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] Paul C. Driscoll,et al. Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins , 1990 .
[41] A M Gronenborn,et al. Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. , 1991, Science.
[42] A T Brünger,et al. Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation. , 1997, Journal of magnetic resonance.
[43] P. Bucher,et al. The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.
[44] Angela M. Gronenborn,et al. The Impact of Direct Refinement against 13Cα and 13Cβ Chemical Shifts on Protein Structure Determination by NMR , 1995 .
[45] Stephen W. Fesik,et al. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain , 1998, Nature.
[46] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[47] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[48] A. Szabó,et al. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results , 1982 .
[49] A. Palmer,et al. Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. , 1995, Journal of molecular biology.
[50] L. Kay,et al. A Gradient-Enhanced HCCH-TOCSY Experiment for Recording Side-Chain 1H and 13C Correlations in H2O Samples of Proteins , 1993 .
[51] P. Krammer,et al. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. , 1999, The Journal of clinical investigation.
[52] Young In Park,et al. The Solution Structure of FADD Death Domain , 1999, The Journal of Biological Chemistry.
[53] P. Driscoll,et al. NMR exchange broadening arising from specific low affinity protein self-association: Analysis of nitrogen-15 nuclear relaxation for rat CD2 domain 1 , 1999, Journal of biomolecular NMR.
[54] S. Sisodia. Nuclear Inclusions in Glutamine Repeat Disorders Are They Pernicious, Coincidental, or Beneficial? , 1998, Cell.
[55] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[56] E. Olejniczak,et al. The lymphoproliferation mutation in Fas locally unfolds the Fas death domain , 1997, Nature Structural Biology.
[57] G. Otting,et al. NMR structure of the death domain of the p75 neurotrophin receptor , 1997, The EMBO journal.
[58] S. Grzesiek,et al. Measurement of HN-Hα J couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods , 1994, Journal of biomolecular NMR.
[59] J. Blenis,et al. Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine Repeats , 1999, Neuron.
[60] C. Cotman,et al. Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8 , 1999, Neurobiology of Disease.
[61] D. Goeddel,et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.
[62] J. Camonis,et al. Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) , 1995, The Journal of Biological Chemistry.
[63] J. Tschopp,et al. The death domain motif found in Fas (Apo‐1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance , 1995, FEBS letters.
[64] Emad S. Alnemri,et al. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1 , 1999, Nature.
[65] K. Wüthrich,et al. Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling. , 1989, Biochemistry.
[66] Gerhard Wagner,et al. Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.
[67] A. Kimchi,et al. The death domain: a module shared by proteins with diverse cellular functions. , 1995, Trends in biochemical sciences.
[68] D. Banner,et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.
[69] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[70] G. Lipari. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules , 1982 .
[71] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[72] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.